Neuroendocrine tumors and rare gastrointestinal malignancies represent a diverse and complex group of diseases with variable clinical behavior. Improved awareness, advanced imaging, and biomarker development have led to increased detection. Accurate classification and staging are essential for appropriate management. Treatment often requires individualized strategies involving surgery, endoscopic therapy, systemic treatment, and targeted approaches. Long-term surveillance is critical due to the risk of recurrence and progression. This topic addresses diagnostic challenges, evolving therapeutic options, and multidisciplinary management of rare GI cancers.
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Nanoemulsions as a strategy to enhance gastrointestinal bioavailability and bioactivity of lipid based nutraceuticals
Pubali Dhar, University of Calcutta, India
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : Sickle cell liver disease: A multidisciplinary hemato-hepatology approach
Bandar Aljudaibi, King Faisal Specialists Hospital and Research Centre, Saudi Arabia
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy